Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer

Biochemical and Biophysical Research Communications

Volumn 448, Issue 4, 2014, Pages 467-472

  Köhler, Christina U ^a   Martin, Laura ^a   Bonberg, Nadine ^a   Behrens, Thomas ^a   Deix, Thomas ^b   Braun, Katharina ^b   Noldus, Joachim ^b   Jöckel, Karl Heinz ^c   Erbel, Raimund ^c   Sommerer, Florian ^a   Tannapfel, Andrea ^a   Harth, Volker ^d   Käfferlein, Heiko U ^a   Brüning, Thomas ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Automation; Bladder cancer; Fluorescence in situ hybridization; Image analysis

Indexed keywords

AGED; ARTICLE; AUTOANALYSIS; BLADDER CANCER; BLADDER CANCER DETECTION KIT; CANCER DIAGNOSIS; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HUMAN; IMAGE ANALYSIS; MALE; PILOT STUDY; POPULATION DYNAMICS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; URINALYSIS; URINE SEDIMENT;

AUTOMATION; BLADDER CANCER; FLUORESCENCE-IN SITU-HYBRIDIZATION; IMAGE ANALYSIS;

AGED; AGED, 80 AND OVER; AUTOMATION, LABORATORY; CASE-CONTROL STUDIES; CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PILOT PROJECTS; SOFTWARE; URINARY BLADDER NEOPLASMS; URINE;

EID: 84901853840     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.137     Document Type: Article

References (23)

1. D.M. Parkin The global burden of urinary bladder cancer Scand. J. Urol. Nephrol. Suppl. 2008 12 20
2. K.C. Halling, W. King, I.A. Sokolova, R.G. Meyer, H.M. Burkhardt, A.C. Halling, J.C. Cheville, T.J. Sebo, S. Ramakumar, C.S. Stewart, S. Pankratz, D.J. O'Kane, S.A. Seelig, M.M. Lieber, and R.B. Jenkins A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma J. Urol. 164 2000 1768 1775
3. B.W.G. van Rhijn, M. Burger, Y. Lotan, E. Solsona, C.G. Stief, R.J. Sylvester, J.A. Witjes, and A.R. Zlotta Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy Eur. Urol. 56 2009 430 442
4. Y. Lotan, S.F. Shariat, B.J. Schmitz-Drager, M. Sanchez-Carbayo, F. Jankevicius, M. Racioppi, S.J.P. Minner, B. Stohr, P.F. Bassi, and H.B. Grossman Considerations on implementing diagnostic markers into clinical decision making in bladder cancer Urol. Oncol. 28 2010 441 448
5. M.A. Knowles Bladder cancer subtypes defined by genomic alterations Scand. J. Urol. Nephrol. Suppl. 2008 116 130
6. M. Höglund The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles Urol. Oncol. 30 2012 533 540
7. I.A. Sokolova, K.C. Halling, R.B. Jenkins, H.M. Burkhardt, R.G. Meyer, S.A. Seelig, and W. King The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine J. Mol. Diagn. 2 2000 116 123
8. M. Skacel, M. Fahmy, J.A. Brainard, J.D. Pettay, C.V. Biscotti, L.S. Liou, G.W. Procop, J.S. Jones, J. Ulchaker, C.D. Zippe, and R.R. Tubbs Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology J. Urol. 169 2003 2101 2105
9. G.D. Smith, and J.S. Bentz "FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation Cancer Cytopathol. 118 2010 56 64
10. T. Hajdinjak UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing Urol. Oncol. 26 2008 646 651
11. G. Cheung, A. Sahai, M. Billia, P. Dasgupta, and M.S. Khan Recent advances in the diagnosis and treatment of bladder cancer BMC Med. 11 2013 13
12. A.A. Renshaw UroVysion, urine cytology, and the College of American Pathologists: where should we go from here? Arch. Pathol. Lab. Med. 134 2010 1106 1107
13. W.A. Marganski, V. El-Sirgany Costa, M.W. Kilpatrick, T. Tafas, J. Yim, and M. Matthews Digitized microscopy in the diagnosis of bladder cancer: analysis of 3000 cases during a 7-month period Cancer Cytopathol. 119 2011 279 289
14. L. Bubendorf, B. Grilli, G. Sauter, M.J. Mihatsch, T.C. Gasser, and P. Dalquen Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings Am. J. Clin. Pathol. 116 2001 79 86
15. M.G. Friedrich, M.I. Toma, A. Hellstern, K. Pantel, D.J. Weisenberger, J. Noldus, and H. Huland Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer BJU Int. 92 2003 911 914
16. M. Varella-Garcia, B. Akduman, P. Sunpaweravong, M.V. Di Maria, and E.D. Crawford The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer Urol. Oncol. 22 2004 16 19
17. G. Pajor, L. Somogyi, B. Melegh, D. Alpar, B. Kajtar, L. Farkas, M. Kneif, D. Bollmann, L. Pajor, and N. Sule Urovysion: considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria Cytometry A 79 2011 375 382
18. A. Schmermund, S. Möhlenkamp, A. Stang, D. Grönemeyer, R. Seibel, H. Hirche, K. Mann, W. Siffert, K. Lauterbach, J. Siegrist, K.-H. Jöckel, and R. Erbel Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle Am. Heart J. 144 2002 212 218
19. G. Pajor, D. Alpar, B. Kajtar, B. Melegh, L. Somogyi, M. Kneif, D. Bollmann, L. Pajor, and N. Sule Automated signal pattern evaluation of a bladder cancer specific multiprobe-fish assay applying a user-trainable workstation Microsc. Res. Tech. 75 2012 814 820
20. P. Dalquen, B. Kleiber, B. Grilli, M. Herzog, L. Bubendorf, and M. Oberholzer DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine Cancer 96 2002 374 379
21. K.C. Halling, and B.R. Kipp Fluorescence in situ hybridization in diagnostic cytology Hum. Pathol. 38 2007 1137 1144
22. M. Daniely, R. Rona, T. Kaplan, S. Olsfanger, L. Elboim, A. Freiberger, S. Lew, and I. Leibovitch Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology Cancer 111 2007 517 524
23. F. Abogunrin, H.F. O'Kane, M.W. Ruddock, M. Stevenson, C.N. Reid, J.M. O'Sullivan, N.H. Anderson, D. O'Rourke, B. Duggan, J.V. Lamont, R.E. Boyd, P. Hamilton, T. Nambirajan, and K.E. Williamson The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria Cancer 118 2012 2641 2650